MetaCap

Teladoc Health Financial Ratios

NYSE: TDOCHealth CareMedical/Nursing ServicesUSD

5.77+0.23 (+4.15%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Teladoc Health ratio analysis

Teladoc Health earned a net margin of -7.9% in FY 2025, up from -39.0% a year earlier. Gross margin was 69.5% compared with a median of 69.2% over the prior 9 years. Return on equity reached -14.5%, meaning Teladoc Health generated -0.14 dollars of profit for every dollar of shareholders' equity.

Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.

Summary generated from market data by MetaCap's automated system. Methodology

Teladoc Health financial ratios (annual)

Teladoc Health annual financial ratios
RatioFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Price / sales0.490.631.361.597.0916.5410.777.798.285.67
Price / book0.901.091.521.650.901.145.883.213.463.03
Gross margin69.5%70.8%70.8%69.1%68.0%64.3%66.7%69.2%73.6%74.0%
Operating margin-10.4%-39.7%-9.6%-567.3%-13.1%-46.3%-14.5%-17.0%-32.3%-50.9%
Net margin-7.9%-39.0%-8.5%-567.5%-21.1%-44.3%-17.9%-23.2%-45.8%-60.3%
Free cash flow margin11.3%11.0%13.0%7.2%9.1%-5.3%4.8%-2.1%-15.9%-43.8%
Return on equity (ROE)-14.5%-67.1%-9.5%-591.9%-2.7%-3.1%-9.7%-9.6%-19.1%-32.1%
Return on assets (ROA)-7.0%-28.5%-5.0%-314.3%-2.4%-2.7%-6.2%-6.4%-13.0%-24.4%
Debt / equity————0.000.000.00——0.19
Current ratio2.771.773.543.293.703.196.528.533.873.93
Revenue growth-1.5%-1.3%8.1%18.4%85.8%97.7%32.4%79.1%89.4%59.2%

Related